{
Hoffmann-La Roche AG

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-032025-04-031111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-032025-04-031111100
Download SVG
Download PNG
Download CSV

novartis gene therapy shows promise for expanding treatment options in sma

Novartis' intrathecal formulation of onasemnogene abeparvovec (OAV101 IT) has shown positive results in a Phase III study for treating type II spinal muscular atrophy (SMA) in children aged 2-17, potentially expanding the eligible patient population for gene therapy. The treatment demonstrated clinical benefits and a favorable safety profile, with common adverse events being manageable. If approved, OAV101 IT could significantly benefit patients in regions without newborn screening initiatives or those diagnosed later, while projected sales for both OAV101 formulations are expected to rise significantly by 2033.
Yahoo Finance
United States Dollar Hoffmann-La Roche AG BIOGEN Novartis AG ITA ESP USA DEU GBR JPN FRA Show more
Healthcare, Market Report
11:45 03.01.2025

Roche secures ADC rights from Innovent in billion dollar lung cancer deal

Roche has secured the rights to an antibody-drug conjugate (ADC) from Innovent for the treatment of lung cancer in a significant $1 billion deal. This acquisition underscores Roche's commitment to advancing its oncology portfolio and enhancing treatment options for patients.
news.google.com
INNOVENT BIO Hoffmann-La Roche AG CHN
Finance & Economy, News Article
06:34 03.01.2025

swiss economy faces challenges in tourism finance and watchmaking sectors

In 2025, the Swiss economy is projected to grow slightly, with GDP growth revised to 1.5%. The financial sector is recovering post-Credit Suisse crisis, while the pharmaceutical industry faces uncertainties due to potential U.S. drug pricing changes. The food sector must navigate rising commodity prices and shifting consumer demands, particularly in chocolate.
SWI swissinfo.ch
United States Dollar Novartis AG Credit Suisse High Yield Bond Fund, Inc. Hoffmann-La Roche AG Nestlé S.A. CHE Bjorn Sibbern Stefan Brupbacher Jean-philippe Bertschy Show more
Finance & Economy, Market Report
09:25 27.12.2024

trading activity slows ahead of christmas as markets prepare for new year

Trading activity is subdued ahead of the Christmas holidays, with many market participants taking a break. The Dow is up 13% this year, while the Nasdaq 100 has nearly doubled that gain, despite Walmart shares dropping over 3% due to a lawsuit. Oil prices fell as the dollar strengthened, impacting crude costs.
Finanz und Wirtschaft
Euro United States Dollar Japanese Yen Swiss Franc Walmart Inc. Relief Therapeutics Holding SA Micron Technology, Inc. Eli Lilly and Company Novartis AG Tether USDt CNY WISeKey Internat.Holding Ltd. N USD/AMD Broadcom Inc. Qualcomm Inc RumbleOn, Inc. Apple Inc. Arm Holdings plc Hoffmann-La Roche AG Nestlé S.A. Eli Lilly Show more
Finance & Economy, Market Report
07:03 27.12.2024

rapt therapeutics acquires long acting anti-ige antibody for food allergy treatment

Rapt Therapeutics has pivoted after halting its lead program, agreeing to pay $35 million for RPT904, a long-acting anti-IgE antibody in development by Shanghai Jemincare. Targeting food allergies, Rapt aims to start a phase 2b trial next year, anticipating peak U.S. sales of $4.5 billion. Investors have backed the biotech with $150 million, extending its cash runway through the expected delivery of trial data in 2027.
Fierce Biotech
United States Dollar Novartis AG Hoffmann-La Roche AG RAPT Therapeutics, Inc. CHN USA Jean Rochefort Show more
Healthcare, Market Report
14:10 23.12.2024

Swiss businesses optimistic about EU trade deal amid economic resilience

Swiss businesses are optimistic about a new EU trade deal that aims to stabilize relations and enhance market access, crucial for the economy, which is projected to grow by 1.3% in 2025. The agreement will harmonize standards and support the pharmaceuticals sector, despite potential challenges in neighboring Germany. While the deal is a positive step, concerns about foreign demand persist, particularly in light of recent sales declines in the tech and engineering sectors.
MarketScreener
Euro United States Dollar Swiss Franc Hoffmann-La Roche AG FRA CHE DEU Anne-Claude Maurer Jean-philippe Kohler Rudolf Minsch Show more
Finance & Economy, News Article
09:44 23.12.2024

swiss economy faces challenges amid real estate turmoil and corporate struggles

Switzerland faces challenges as families receive eviction notices amid rising real estate speculation, raising concerns about social stability. While the economy shows some resilience compared to the EU, major Swiss companies like Roche and Nestlé struggle with poor management decisions, impacting investor confidence. The promise of a prosperous decade seems overshadowed by the realities faced by many employees and smaller investors.
insideparadeplatz.ch
Swiss Franc Hapag-Lloyd AG Nestlé S.A. Hoffmann-La Roche AG Novartis AG UBS Group AG Kühne + Nagel International AG Deutsche Lufthansa AG ISR CHE DNK RUS USA DEU CHN POL Klaus-Michael Kühne Peter Brabeck-Letmathe Mark Haefele Sergio Ermotti Elon Musk Paul Bulcke Show more
Finance & Economy, Market Report
19:56 20.12.2024

swiss stock exchange declines as investors react to economic uncertainties

The Swiss stock exchange closed lower, with the SMI down 0.26% at 11,384.92 points, marking a 3% loss over the week and reducing year-to-date gains to just 2%. Investor uncertainty stems from the Federal Reserve's cautious approach to interest rate cuts and concerns over a potential U.S. government shutdown. Notable declines were seen in UBS, Partners Group, and various insurance companies, while Idorsia plummeted 50.35% due to delays in drug negotiations.
SWI swissinfo.ch
Swiss Franc United States Dollar Hoffmann-La Roche AG S Tempo Swiss Life AM Novo Nordisk A/S Axon Partners Group, S.A. ABB Ltd Holcim AG Nestlé S.A. Zurich, Agence générale Christian Meier SA Ypsomed Holding AG Novartis AG Credit Suisse Real Estate Fund Siat Sika AG Swiss Re AG Idorsia Ltd Geberit AG CHE Show more
Finance & Economy, Market Report
17:45 20.12.2024

cryopyrin-associated periodic syndrome pipeline analysis and key company insights

DelveInsight's report highlights the ongoing development of therapies for Cryopyrin-Associated Periodic Syndromes (CAPS) by key companies such as Novartis and Zydus Lifesciences. The pipeline includes several promising candidates in various clinical trial phases, with VTX2735 showing significant efficacy in a recent Phase 2 trial. CAPS, caused by NLRP3 gene mutations, leads to severe inflammatory episodes and requires effective treatment to prevent long-term damage.
The Globe and Mail
Novartis AG Aclaris Therapeutics, Inc. Hoffmann-La Roche AG USA Gaurav Bora Show more
Healthcare, Market Report
21:00 19.12.2024

global uveitis treatment market poised for significant growth by 2032

The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
openPR.com
Pfizer Inc. Bayer AG Novartis AG Regeneron Pharmaceuticals, Inc. Merck & Co., Inc. CIPLA LTD Lupin Limited Hoffmann-La Roche AG Bausch Health Companies Inc. BIOGEN ABBVIE Alimera Sciences Inc. SAU ISR FRA RUS DEU TWN ARG ARE AUT TUR SGP NZL CHL USA BRA CAN ITA JPN IDN GBR ESP IND MYS COL AUS THA EGY VNM KOR PHL CHN ZAF MEX Nidhi Bhavsar Show more
Healthcare, Market Report
20:41 19.12.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Finance Mergers & Acquisitions Banking Regulations Retail and Consumer Goods Startups & Entrepreneurship Industry Mergers & Acquisitions Market Analysis and Predictions CEO Changes Inflation and Monetary Impact Government Policies Government Economic Policies Commodities GDP Growth & Recession Forecasts Central Bank Actions Hedge Funds & Private Equity Domestic Politics
Countries:
USA CHN GBR CHE IND FRA CAN JPN ESP DEU ITA SGP MEX ARE BRA VNM AUT LIE TWN BEL
Companies:
Barclays PLC JPMorgan Chase & Co. Apple Inc. Tesla, Inc. Banco Santander, S.A. Berkshire Hathaway Inc. The Goldman Sachs Group, Inc. Commerzbank AG Amazon.com, Inc. NVIDIA Corporation Morgan Stanley Lloyds Banking Group plc Bank of America Corporation Wells Fargo & Company SpaceXCoin USD Deutsche Bank Money Market PP Citigroup Inc. Microsoft Corporation Royal Bank of Canada UBS Group AG
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Indian Rupee Japanese Yen Chinese Yuan New Taiwan Dollar Canadian Dollar United Arab Emirates Dirham South Korean Won Vietnamese Đồng Danish Krone Indonesian Rupiah Russian Ruble Singapore Dollar Chilean Peso Egyptian Pound Cambodian Riel
People:
Donald Trump Elon Musk Warren Buffett Troy L Rohrbaugh Alex Kramm JD Vance Robin Leopold Pierin Vincenz Carsten Fritsch Ana Botina Jeff Bezos Stacey Friedman Karoline Leavitt Stefan Rauti Manav Patnaik Jesús Aguado Inti Landauro Mark Zuckerberg Ana Patricia Botin Ashwani Verma

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.